COPD (Chronic Obstructive Pulmonary Disease)
Study:
"Intravenous MSCs improve lung function in patients with COPD: a pilot trial."
Findings: MSCs reduce inflammation and improve respiratory function and quality of life in COPD patients. Source: Stem Cell Research & Therapy
Long-COVID
Study:
"Mesenchymal stem cells for post-COVID lung syndrome: clinical evidence."
Findings: MSCs repair lung tissue and reduce inflammation in patients with Long-COVID. Source: Journal of Translational Medicine
Asthma
Study:
"MSC-based therapy reduces airway inflammation in allergic asthma."
Findings: MSCs improve airway function and reduce inflammation in asthma patients. Source: Stem Cell Research & Therapy
Longevity Medical Institute (C) Copyright. All Rights Reserved.
35
Made with FlippingBook Annual report maker